Use of G-CSF for granulocyte transfusion therapy

Cytokines, Cellular and Molecular Therapy

Volumn 6, Issue 2, 2000, Pages 89-95

  Hubel, K ^a   Dale, D C ^a   Engert, A ^a   Conrad Liles, W ^a  

^a Division of Infectious Diseases   (United States)

Author keywords

G CSF; Granulocytes; Infection; Neutropenia; Transfusion

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

BLOOD DONOR; BLOOD STORAGE; CELL COUNT; CELL VIABILITY; CHILL; DRUG EFFICACY; FEVER; GRANULOCYTE TRANSFUSION; HUMAN; HYPOTENSION; LEUKAPHERESIS; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW;

EID: 0033714418     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: 10.1080/13684730050515813     Document Type: Review

References (68)

1. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
2. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions
3. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: A retrospective analysis
4. Granulocyte colony-stimulating factor - Role and relationships in infectious diseases
5. The effect of leukocytic cream injections in the treatment of the neutropenias
6. Transfusions of separated leukocytes into irradiated dogs with aplastic marrows
7. Comparison of agents producing a neutrophilic leukocytosis in man: Hydrocortisone, prednisone, endotoxin and etiocholanolone
8. Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method, donor corticosteroid treatment, and short-term storage
9. In vitro function and post transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis
10. Therapeutic granulocyte transfusions in 1993
11. Sepsis: The role of steroids and monoclonal antibodies in treatment
12. A comparative trial of granulocyte-colony stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophlls in the peripheral blood of normal volunteers
13. The clinical use of colony stimulating factors
14. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells
15. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor
16. Review: Nomenclature and biologic significance of cytokines involved in inflammation and the host immune response
17. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferongamma
18. Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions
19. CSF-G, Respiratory burst in adherent human neutrophils triggering by colony-stimulating factors CSF-GM
20. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils
21. In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophll oxidative functions in normal human volunteers
22. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Comparisons and potential for use in the treatment of infections in non neutropenic patients
23. Recombinant human granulocyte-macrophage colony-stimulating factor produces fever
24. GM-CSF therapy and capillary-leak syndrome
25. Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions
26. Granulocyte and granulocyte-macrophage colony-stimulating factors
27. Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases
28. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer
29. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
30. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings
31. Filgrastim (r-metHuG-CSF): The first 10 years
32. Renewed interest in granulocyte transfusion therapy
33. A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults
34. Current approach to the management of neutropenia
35. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function
36. Neutrophil transfusion for treatment of infections
37. Neutrophil transfusion: The effect of storage and collection method on neutrophil blood kinetics
38. Granulocyte transfusion therapy
39. Granulocyte transfusions from granulocyte colony-stimulating factor-treated donors: Also a question of cell survival?
40. 2-integrins
41. stored after administration of G-CSF, Functional characteristics of neutrophils collected
42. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte colony-stimulating factor (G-CSF)
43. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients
44. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia
45. Transfusion of neutrophils as prevention or tratment of infection in patients with neutropenia
46. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis
47. Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocytecolony-stimulating factor and dexamethasone
48. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans
49. Return of granulocyte transfusions
50. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection
51. An examination of ethical issues raised in the pretreatment of normal volunteer granulocyte donors with granulocyte colony-stimulating factor
52. Clinical perspectives of granulocyte transfusions efficacy to date
53. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation
54. Granulocyte transfusion in neutropenic patients
55. Granulocyte transfusions
56. Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor
57. The pathology of transfusion-related acute lung injury
58. Transfusion related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria
59. Neutrophil antibodies
60. Effects of in vitro and in vivo cytokine treatment, leukapheresis and irradiation on the function of human neutrophils: Implications for white blood cell transfusion therapy
61. Normal granulocyte transfusion therapy
62. Filtration leukapheresis for granulocyte transfusion therapy
63. Granulocyte transfusion: A controlled study in patients with acute nonlymphocytic leukemia
64. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia
65. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia
66. Successful granulocyte transfusion therapy for gram-negative septicemia
67. Therapeutic granulocyte transfusions for documented infections A controlled trial in ninety-five infectious granulocytopenic episodes